MicroTransponder Inc. (MTI) news

MicroTransponder Inc., today announced that the pivotal clinical trial results for the Company`s investigational Vivistim® Paired Vagus Nerve Stimulation (VNS) System have been published in The Lancet.  Each year in the US, 50-60% of the 658,000 stroke survivors have upper extremity motor d

MicroTransponder, Inc., (www.microtransponder.com) a privately-held medical device company, is pleased to announce that its successful stroke rehabilitation clinical trial has been published in the prestigious academic journal Stroke. The manuscript, titled "Safety, Feasibility and Efficacy of Vagus Nerve Stimulation (VNS) Paired with Arm Rehabilitation Following Ischemic Stroke" reports clinical results from a paired V